Introduction
Essential Tremor (ET) is the most common movement disorder, affecting more than 300,000 Australians and millions more worldwide. There is currently no cure for ET and combined studies suggest 50-70% response rates with average tremor reduction of about 50% from available medications. If you have a disabling the tremor that affects your daily activities and does not improve with medication, you may consider surgical treatment.
Advances in understanding brain anatomy, improved imaging methods and refined surgical techniques have led to greater surgical accuracy and increased benefits with fewer complications. Surgical procedures for ET include thalamic deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS).
This guide provides an overview of the history of surgical options for ET, descriptions of current surgical procedures and the risks and benefits to consider when contemplating surgery.
History of surgical treatment
Surgeons have been performing surgery for tremor disorders for almost 100 years. Initially, surgery involved the destruction of large parts of the brain, which resulted in an improvement in the tremor but significant side effects such as weakness and paralysis.
In 1947, surgeons first used stereotactic surgical techniques in humans. These techniques involve using electrodes to precisely locate a particular part of the brain without destroying surrounding brain areas, allowing for improvement in the tremor with fewer side effects.
To achieve optimal the tremor control, it was necessary to determine the specific part of the brain to target for surgery. By the late 1950s, researchers identified the ventral intermediate (VIM) nucleus of the thalamus as the most effective target for treating the tremor. The thalamus is a group of cells deep in the brain involved in relaying motor and sensory signals from different portions of the brain. Creating a lesion or destroying a portion of the VIM nucleus of the thalamus is called thalamotomy.
The brain has two halves and each side controls movement and sensation on the opposite side of the body. For instance, doctors found that performing thalamotomy on the left side of the brain (a unilateral procedure) effectively controls the tremor on the right side of the body. However, thalamotomy on both sides of the brain (bilateral procedure) to improve the tremor on both sides often resulted in speech, balance and memory problems.
In 1993, Europe approved deep brain stimulation (DBS) of the thalamus as a treatment for ET. In 1997, the United States approved this treatment as well. DBS was first performed in Australia in 1997 with the assistance of Professor Benabid, the French neurosurgeon who developed the procedure. Researchers found that DBS offers similar benefits to thalamotomy, but with fewer complications. In DBS, there is no destruction of the brain. Instead, surgeons place a wire (electrode or lead) in the VIM nucleus of the thalamus. The wire is connected under the skin to a pacemaker-like battery device typically placed in the chest, providing mild electrical currents to control symptoms. In ET, DBS of the VIM nucleus of the thalamus is the most commonly used surgical procedure to control the tremor.
In 2011, doctors performed the first MR-guided focused ultrasound thalamotomy to treat ET. This procedure involves focusing sound waves through the skull onto the thalamus, which destroys a portion of the VIM nucleus to reduce the tremor. In 2012, Europe approved a focused ultrasound system for people whose tremor did not respond to medication. The US Food and Drug Administration approved this treatment for ET in 2016. In Australia, St Vincent’s Hospital in Sydney became the first hospital in Australia and the Southern Hemisphere to offer MR-guided focused ultrasound therapy (MRgFUS) in 2018. In March 2024, MR-guided focused ultrasound became available through Medicare in Australia, making this treatment option more accessible for Australians with ET.
Patient selection
Doctors consider surgery for people with ET when medications, such as propranolol or primidone, do not provide enough control and the tremor remains disabling. A disabling tremor is one that noticeably interferes with daily living, making it difficult to eat, write, drink, groom, pursue hobbies or stay in employment.
Before recommending surgical options, your doctor will usually ensure you have tried the main medication treatments. If these drugs do not help enough and the tremor continues to limit your independence or quality of life, surgery may be suitable.
Not everyone is eligible for surgery. Doctors do not recommend surgical treatments for people who have significant memory or thinking problems (cognitive impairment) or for those with unstable medical conditions that would increase the risk of complications during or after surgery. A multidisciplinary team, which includes a neurologist, carefully checks all available options and considers whether surgery is likely to improve your daily function. In Australia, Medicare funding for procedures like deep brain stimulation (DBS) or MR-guided focused ultrasound (MRgFUS) requires that:
- You are an adult with ET that does not respond to medication.
- Your tremor predominantly affects movement in your arms or hands.
- The tremor has a severe impact on your daily life and ability to live independently.
- Your healthcare team will work with you and your family to weigh up the benefits and risks and to support your decision-making about surgery.
Deep Brain Stimulation (DBS)
Currently, the most common surgical treatment for ET in Australia is Deep Brain Stimulation (DBS). With DBS, doctors implant an electrode into the ventral intermediate (VIM) nucleus of the thalamus and deliver electrical stimulation to the brain. It is the most effective treatment for the tremor, with the most significant effect on hand and arm tremor. It may also help control head, voice and leg tremor.
Doctors can perform DBS on one side (unilateral) or both sides (bilateral) of the brain. However, operating on both sides increases the risk of speech and balance problems. If the tremor significantly affects both hands, doctors usually target the dominant hand first. In some cases, they may consider a procedure on both sides. Doctors connect the implanted electrode(s) in the brain to a neurostimulator (battery), which provides the right amount of electrical stimulation to control tremor. Although DBS can significantly reduce the tremor, it is essential to remember that it is not a cure for ET.
TGA-approved DBS systems in Australia
The Therapeutic Goods Administration (TGA) has approved several DBS systems for the treatment of ET and all significantly reduce the tremor. These include:
- Abbott’s Liberta RC™ DBS system – the world’s smallest rechargeable DBS system with remote programming capabilities
- Medtronic Percept™ PC system – advanced DBS with brain sensing technology
- Boston Scientific DBS systems – various models approved for movement disorders
- If you choose to receive DBS, you should discuss with your neurologist and neurosurgeon which device would be best for you.
Medicare coverage for DBS
Medicare covers DBS for ET under specific item numbers:
- Item 40851: Bilateral DBS insertion – This covers the surgical implantation of DBS electrodes in both sides of the brain. The fee: $4,623.20, Benefit: $3,467.40 (75%)
- Item 40852: Unilateral pulse generator placement – This covers the placement of the pulse generator (battery pack) on one side of the body. The fee: $397.25, Benefit: $297.95 (75%)
- Item 40863: Remote programming sessions – This allows for remote programming of the DBS device, with up to 8 sessions per year covered. The fee for each session is $200.55.
Medicare provides cover for DBS when ET causes severe disability and medication does not adequately control symptoms.
Australian DBS centres
Public hospitals:
- The Royal Melbourne Hospital – Movement Disorders Program
- Princess Alexandra Hospital, Brisbane – Comprehensive movement disorders services
- Royal Perth Hospital – Neurology services with DBS capability
- Westmead Hospital DBS clinic: Quality care with compassion and equity for all. Established in 2006
Specialist private centres:
- St Andrew’s War Memorial Hospital, Brisbane – Prof Peter Silburn and Dr Terry Coyne team (1,350+ procedures completed, world leaders who trained 85% of Australian DBS teams)
- Melbourne Deep Brain Stimulation (Cabrini Hospital) – A/Prof Wesley Thevathasan and Dr Kristian Bulluss team
- North Shore Private Hospital, Sydney – over 500 procedures completed
- Central Neurosurgery, Sydney – Dr Benjamin Jonker
- Calvary Adelaide Hospital – Dr Andrew Zacest
- Hollywood Private Hospital, Perth – Dr Julian Rodrigues (providing DBS since 2004)
- Westmead Private Hospital, Sydney: A.Prof Neil Mahant / Dr Nagaratnam / Dr Jessica Qiu
- Sydney Adventist Hospital: Dr Jessica Qiu
Pre-operative preparation
Before surgery, a specially trained neurosurgeon will take detailed scans of your brain to help plan exactly where to place the electrode. There are two ways to do this: sometimes a frame is gently attached to your head with a few small screws (you’ll have local anaesthetic so the area is numb) or the team might use a “frameless” method with just small screws. Once everything is in place, you’ll have a CT or MRI scan so the doctor can see clear pictures of your brain and pinpoint the perfect spot for treatment.
Next, the team will clean and shave a small area on top of your head. With local anaesthetic to keep you comfortable, they’ll make a tiny opening in your skull, which is about the size of a five-cent coin, so that they can proceed with the surgery. The team carefully plans the whole process to keep you safe and comfortable at every step.
The procedure
During the procedure, most people stay fully awake while the team places the electrode in the brain. Because the brain itself doesn’t have pain receptors, you won’t feel any pain during this step. Although you don’t have to be awake, it helps the surgical team to see right away how the stimulation affects your tremor and to watch for any side effects.
Both awake and asleep (general anaesthetic) approaches are valid options for Deep Brain Stimulation (DBS) surgery. While many centres traditionally perform DBS with the person awake so that they can test symptom response during the operation, advances in imaging and surgical planning allow some people to have DBS under general anaesthetic if needed. Recent research shows that both awake and asleep approaches offer similar outcomes. Your team can tailor the decision to your comfort, health and the preferences of your surgical team.
If you have surgery while awake, the team will ask you to do simple tasks like drawing a spiral or holding a cup to assess the effectiveness of the electrode placement. When the team reaches the right spot, your tremor should suddenly improve, which helps them confirm the electrode is effective and manage any side effects straight away.
Once the neurosurgeon confirms the placement, they leave the electrode in place. Either on the same day or about a week later, a small neurostimulator (battery) is implanted under the skin in your chest and connected to the electrode with a thin wire. This wire runs under your skin from the chest to the brain. These wires and the battery all sit under the skin so that you won’t see them.
The whole procedure usually takes about three to four hours.
Post-operative care
A few weeks or so after your surgery, your doctor or nurse will switch on your device and begin adjusting the settings to help control your tremor as much as possible. Most people don’t feel the stimulation at all, though you might notice a gentle tingling when it’s first turned on. Fine-tuning the device can take a few programming sessions to get things just right.
After the operation, you’ll most likely spend one night in the hospital and then head home to rest. It’s essential to take it easy as you recover and typically, within a few weeks, you can usually get back to your regular daily routines. Your doctor will give you individual advice, but for most people it’s safe to start easing back into activities that were tricky before the surgery as you regain your confidence.
Considerations and risks
DBS involves placing foreign objects in the brain, increasing the risk of infection and other complications. The most serious risks include infection, bleeding inside the brain and seizures, but these occur in less than 5% of people. Some complications can be severe and, although rare, may be fatal.
Once implanted, the system may rarely become infected, parts may wear through the skin or the device may malfunction. Any of these situations may require additional surgery or cause ET symptoms to return. When implanted on both sides of the brain, DBS may cause speech and language problems.
The system’s battery needs replacement every 3-7 years, depending on stimulation settings used. Battery replacement is an outpatient procedure covered by Medicare. Rechargeable systems are also available.
Important precautions
Avoid diathermy (electric currents used to generate heat in tissue), often used in surgery, physiotherapy and dentistry.
If you need an MRI scan, contact your surgical centre first – MRIs can generally be performed safely with proper precautions.
If the device is not effective for you or a new treatment becomes available, your doctors can remove it without damaging any brain tissue.
Outcomes
Studies demonstrate DBS has comparable tremor improvement to thalamotomy but with fewer complications. The majority of studies report improvements in the tremor in 90% of people. Long-term studies show improvement is maintained in most people for at least 7-10 years after surgery, though benefits may reduce over time.
Multiple studies demonstrate immediate and long-term benefits:
- Hand tremor improvement: approximately 90%
- Functional ability improvement: approximately 85%
- Head and voice tremor: also shows improvement, with the greatest improvements seen with bilateral procedures
Other uses
DBS is used to treat various neurological conditions, including Parkinson’s, dystonia and obsessive-compulsive disorder. Researchers are studying DBS as a treatment for severe depression, epilepsy, Tourette’s syndrome and other conditions such as obsessive-compulsive disorder, chronic pain and addiction.
Australia has world-leading expertise in DBS techniques, with Australian teams pioneering innovations such as general anaesthetic DBS guided by brain signals and novel brain signal navigation techniques.
Magnetic Resonance-Guided Focused Ultrasound (MRgFUS)
Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) is a non-invasive surgical treatment for ET. This procedure uses highly focused ultrasound energy to target and treat the area of the brain responsible for the tremor, without the need to make any incisions or insert hardware into the brain.
Australia first introduced MRgFUS for ET at St Vincent’s Hospital, Sydney, in 2018, with Medicare coverage beginning in March 2024. Thanks to recent changes, Australians with medication-resistant ET can now access this therapy in several public and private centres across the country.
Pre-procedure
Before the procedure, you will have a comprehensive assessment by a specialist team, including a neurologist and a neurosurgeon, to make sure this treatment is suitable for you. The team will review your tremor history and response to medication, check your overall health (including memory and thinking) and arrange for an MRI scan to map your brain and guide the treatment. You’ll also have blood tests and general health checks to ensure you’re fit for the procedure. The team will explain what to expect, answer any questions and make sure you know how to prepare (for example, you may need to stop eating or drinking for a specific period beforehand).
The procedure
On the day, the medical team will fit a lightweight head frame using local anaesthetic to keep your head still and comfortable throughout the session. You will then lie inside an MRI scanner. The MRI constantly monitors your brain and helps the team target the right spot (the ventral intermediate or VIM, nucleus of the thalamus).
Using computer controls, they direct over a thousand focused ultrasound beams through your skull, all converging on a tiny spot in the brain. Where the beams meet, the energy creates heat that destroys a small group of tremor-causing cells.
During the procedure, you will be able to talk to the team. The team will ask you to do simple tasks, such as drawing or holding a cup between each “sonication” (the ultrasound pulses), so they can see how your tremor improves in real time. Most people notice their tremor decrease immediately. The session usually lasts a few hours and most people go home the same day or after an overnight stay.
Considerations and risks
MRgFUS is generally well-tolerated and does not require any surgical cuts or implants. Because it doesn’t involve opening the skull, the risk of infection and bleeding is very low.
Common short-term side effects include:
- Mild headache or nausea after treatment
- Temporary tingling or numbness on one side of the body
- Balance or walking problems (unsteadiness), sometimes lasting days to weeks
Long-term, a small percentage of people may have mild persistent numbness or imbalance. The most serious risks, though rare, include more lasting sensory changes or walking/balance difficulties. MRgFUS works by creating a minor burn (lesion) in the part of the brain that causes the tremor, so the effects are permanent and cannot be reversed. The procedure is currently performed on one side of the brain only, usually targeting the dominant hand.
Not everyone is a candidate for MRgFUS. People with significant cognitive problems, unstable medical conditions or specific skull shapes (which affect how ultrasound passes through) may not be eligible.
Outcomes
Australian and international studies show that most people treated with MRgFUS experience a marked and immediate improvement in their tremor, often reducing by 50-60% or more and can more easily carry out daily tasks like eating, writing and drinking. Benefits are typically reported straight after the procedure, with many continuing to enjoy these gains for months or years. Final results can vary depending on individual factors. There is less need for ongoing adjustments or hospital visits compared to treatments involving implants.
MRgFUS is covered by Medicare under new MBS item numbers (40804, 40805, 40806, 63019 and 63020), making it relatively affordable and widely accessible.
Access and availability
You can discuss MRgFUS with your neurologist or movement disorder specialist, who can refer you to a centre offering the procedure. Specialist hospitals and clinics now providing MRgFUS for ET in Australia include:
- St Vincent’s Hospital, Sydney (first and leading centre)
- Gold Coast University Hospital
- Precision Brain, Spine and Pain (Melbourne)
- Central Neurosurgery Sydney
- Epworth Hospital (Melbourne)
- Northern Neuroscience, Sydney
Check with your treating team for the most up-to-date list and referral pathways.



